Global Medical Cold Plasma Market Growth 2024-2030
Medical Cold Plasma is also called as non-thermal plasma and used in wide range of applications in various industries including medical and biomedical industries. It is a powerful tool, which used to provide antimicrobial treatment for wounds and injuries.
The global Medical Cold Plasma market size is projected to grow from US$ 115 million in 2024 to US$ 393 million in 2030; it is expected to grow at a CAGR of 22.7% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Medical Cold Plasma Industry Forecast” looks at past sales and reviews total world Medical Cold Plasma sales in 2023, providing a comprehensive analysis by region and market sector of projected Medical Cold Plasma sales for 2024 through 2030. With Medical Cold Plasma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Cold Plasma industry.
This Insight Report provides a comprehensive analysis of the global Medical Cold Plasma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Cold Plasma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Cold Plasma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Cold Plasma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Cold Plasma.
Global key players of Medical Cold Plasma include Apyx Medical Corporation, ADTEC Plasma Technology, Neoplas med GmbH, etc. The top three players hold a share about 75%. United States is the largest market, and has a share about 51%, followed by Europe and Japan with share 37% and 5%, separately. In terms of product type, Indirect-discharge is the largest segment, occupied for a share of 85%. In terms of application, Wound Healing has a share about 81 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Cold Plasma market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Direct-discharge
Indirect-discharge
Segmentation by Application:
Wound Healing
Aesthetic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Apyx Medical Corporation
ADTEC Plasma Technology
Neoplas med GmbH
Terraplasma Medical GmbH
CINOGY System GmbH
D.B SkinTech
US Medical Innovations
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Cold Plasma market?
What factors are driving Medical Cold Plasma market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Cold Plasma market opportunities vary by end market size?
How does Medical Cold Plasma break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.